相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。AKT Inhibition Relieves Feedback Suppression of Receptor Tyrosine Kinase Expression and Activity
Sarat Chandarlapaty et al.
CANCER CELL (2011)
PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer
V. Serra et al.
ONCOGENE (2011)
HER-3 Overexpression Is Prognostic of Reduced Breast Cancer Survival A Study of 4046 Patients
Connie G. Chiu et al.
ANNALS OF SURGERY (2010)
HER3 Comes of Age: New Insights into Its Functions and Role in Signaling, Tumor Biology, and Cancer Therapy
Marcia R. Campbell et al.
CLINICAL CANCER RESEARCH (2010)
Metalloproteinase-dependent cleavage of neuregulin and autocrine stimulation of vascular endothelial cells
April Kalinowski et al.
FASEB JOURNAL (2010)
Management of breast cancer with targeted agents: importance of heterogenicity
Serena Di Cosimo et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
The role of HER3, the unpretentious member of the HER family, in cancer biology and cancer therapeutics
Dhara N. Amin et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2010)
Phosphoinositide 3-kinases in cell migration
Robert J. Cain et al.
BIOLOGY OF THE CELL (2009)
The EGF/CSF-1 Paracrine Invasion Loop Can Be Triggered by Heregulin β1 and CXCL12
Lorena Hernandez et al.
CANCER RESEARCH (2009)
Neuregulin-1β Is Associated With Disease Severity and Adverse Outcomes in Chronic Heart Failure
Bonnie Ky et al.
CIRCULATION (2009)
ERBB1 and ERBB2 Have Distinct Functions in Tumor Cell Invasion and Intravasation
Dmitriy Kedrin et al.
CLINICAL CANCER RESEARCH (2009)
Novel anticancer targets: revisiting ERBB2 and discovering ERBB3
Jose Baselga et al.
NATURE REVIEWS CANCER (2009)
EGFR family: Structure physiology signalling and therapeutic targets
Antony W. Burgess
GROWTH FACTORS (2008)
Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patients
Andrea Sassen et al.
BREAST CANCER RESEARCH (2008)
Synthesis and biological evaluation of sulfonylhydrazone-substituted imidazo[1,2-a]pyridines as novel PI3 kinase p110α inhibitors
Masahiko Hayakawa et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Distinct ErbB-2-coupled signaling pathways promote mammary tumors with unique pathologic and transcriptional profiles
Babette Schade et al.
CANCER RESEARCH (2007)
Intra- and extracellular signaling by endothelial neuregulin-1
Erika Iivanainen et al.
EXPERIMENTAL CELL RESEARCH (2007)
Evidence for functional redundancy of class IA PI3K isoforms in insulin signalling
Claire Chaussade et al.
BIOCHEMICAL JOURNAL (2007)
MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling
Jeffrey A. Engelman et al.
SCIENCE (2007)
Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors
Jeffrey B. Wyckoff et al.
CANCER RESEARCH (2007)
ErbB3-dependent motility and intravasation in breast cancer metastasis
CS Xue et al.
CANCER RESEARCH (2006)
A quantitative protein interaction network for the ErbB receptors using protein microarrays
RB Jones et al.
NATURE (2006)
High expression of ErbB family members and their ligands in lung adenocarcinomas that are sensitive to inhibition of epidermal growth factor receptor
N Fujimoto et al.
CANCER RESEARCH (2005)
ErbB-3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive non-small cell lung cancer cell lines
JA Engelman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation
T Holbro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Roles of mitogen-activated protein kinase and phosphoinositide 3′-kinase in ErbB2/ErbB3 coreceptor-mediated heregulin signaling
U Vijapurkar et al.
EXPERIMENTAL CELL RESEARCH (2003)
Heregulin-dependent activation of phosphoinositide 3-kinase and Akt via the ErbB2/ErbB3 co-receptor
NJ Hellyer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
An essential role for Src kinase in ErbB receptor signaling through the MAPK pathway
MA Olayioye et al.
EXPERIMENTAL CELL RESEARCH (2001)
Molecular requirements for the effect of neuregulin on cell spreading, motility and colony organization
A Chausovsky et al.
ONCOGENE (2000)